BioChem Pharma initiates new Troxatyl trials

Based on preliminary data from an ongoing Phase II trial, BioChem (BCHE; TSE:BCH) plans to initiate new studies of Troxatyl troxacitabine, a dioxolane nucleoside analog that inhibits DNA polymerase, t...